Cardiovascular Disease

Fatal outcomes in COVID-19 were associated with patients with CVD and risk factors such as hypertension and diabetes across all age groups, according to a meta-analysis.

Regular intake of glucosamine/chondroitin was associated with lower all-cause and CVD mortality among adults aged older than 40 years in the United States, data from a cohort study showed.

Women with early ovarian aging are more likely to incur age-related diseases than those with normal ovarian aging, according to study results published in Human Reproduction.

Ideal CV health behaviors were associated with lower nonalcoholic fatty liver disease, or NAFLD, prevalence among participants in the Multi-Ethnic Study of Atherosclerosis cohort.

The COVID-19 pandemic was on the minds of Healio readers for most of 2020, and some of the most-read articles involved research to lessen COVID-19 complications and recommendations for reducing risk for exposure in those with diabetes.

Frequent nightmares were associated with psychological disturbances and insomnia in patients hospitalized for CVD, according to a study published in the European Journal of Cardiovascular Nursing.

Using clinical data, serum biomarkers and multi-biomarker disease activity, researchers have developed and validated a prognostic score that can predict 3-year cardiovascular risk in patients with rheumatoid arthritis, according to findings.

The relationship between HIV and arterial endothelial function may imply CVD risk among infected patients, particularly if they also have kidney disease, according to a study published in Arteriosclerosis, Thrombosis, and Vascular Biology.

CV events cause substantial morbidity and mortality among patients with rheumatologic diseases. Moreover, a robust body of data chronicles these associations.

Baseline depressive symptoms appeared modestly associated with cardiovascular disease incidence, including at symptoms levels below a typical depressive disorder threshold, according to study results published in JAMA.